Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Interactive Brokers Group heads into the final week of August with short sellers retreating at an unusual pace — while the analysts who cover it are still catching up to a stock that has already moved through most of their targets.
The most striking data point this week is the speed of short covering. Short interest dropped 13% in a single session on August 25, pulling the 30-day decline to nearly 30%. The position now amounts to just 1.8% of the free float — a level too small to drive meaningful price action on its own. What makes it notable is the timing: the covering accelerated as the stock added 8.4% over the week to close at $98.19, a move that appears to have flushed out residual bearish positioning. Borrow conditions offer no ammunition to rebuild shorts. Cost to borrow is running at just 0.28%, the lowest in six weeks, and availability is essentially unlimited — the share lending pool is barely 0.5% drawn. There is no structural friction preventing new shorts from entering if sentiment turned, but the economics offer no incentive to hold a position against a stock in this kind of momentum.
Options positioning echoes the same cautiously bullish tone. The put/call ratio is at 0.65, slightly above its 20-day average of 0.63 but well within one standard deviation — this is not a market bracing for a reversal. The 52-week high on the PCR is 0.93, so current readings are closer to relaxed than defensive. The ORTEX short score has eased to 29.8, down from 30.7 a week ago, reinforcing that aggregate short-side pressure is waning rather than building.
The Street is unanimously bullish but has been in catch-up mode all year. Following Q2 results in late July, BMO Capital lifted its target to $110 and Barclays moved to $114, both maintaining positive ratings. Bank of America had already pushed its target from $83 to $106 after the prior quarter's print. The consensus mean now sits at roughly $106 — an 8% premium to the current price, but that gap has been narrowing fast as IBKR has rallied 44% year-to-date. The stock is trading above Goldman Sachs' April target of $98 already, which underscores how quickly results have outpaced Street pencils. The ORTEX factor scores add texture: EPS momentum on a 90-day basis ranks in the 88th percentile, and EPS surprise in the 74th — the company has consistently beaten estimates. The days-to-cover rank at 78 reflects a position that is already lean. The one soft spot in the factor picture is forward earnings growth, where the 12-month forward year-on-year increase ranks only in the 35th percentile, suggesting the market is paying for current profitability rather than a steep growth ramp.
Institutional flow looks broadly constructive. BlackRock added 1.75 million shares in the most recent reported period, bringing its stake to 7.3% of shares. Invesco added over 600,000 shares. The more notable line in the ownership table is founder Thomas Peterffy, who still holds 1.34% of shares with no reported change. On the insider side, the picture is mixed but not alarming. The May 8 cluster of executive sales — CEO Milan Galik sold $21.5 million worth and CFO Paul Brody sold $7 million — was meaningful in size, though timing around compensation cycles limits the signal value. Since then, the only insider activity has been a director's recurring small purchases, barely $2,200 at a time. Net insider value over the past 90 days is technically positive at $34 million, but that figure is dominated by Galik's sale in the opposite direction — it reflects reporting timing, not net accumulation.
Among peers, Robinhood had the standout week, up 22% as retail brokerage sentiment ran hot. FUTU added nearly 16%. IBKR's 8.4% gain looks measured by comparison, suggesting the move was driven by its own fundamental narrative rather than a pure sector beta trade. The next scheduled catalyst is Q3 earnings on October 13. With the stock now trading at roughly 31x trailing earnings and a price-to-book of 5.5x — both near the top of recent ranges — that print will be the next real test of whether the Street's target-lifting cycle has further to run.
See the live data behind this article on ORTEX.
Open IBKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
